14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Sep 24, 2019 $0.0485 $0.0485 $0.0400 $0.0485 6 917
Sep 23, 2019 $0.0500 $0.0500 $0.0400 $0.0485 16 907
Sep 20, 2019 $0.0400 $0.0485 $0.0400 $0.0485 4 579
Sep 19, 2019 $0.0375 $0.0576 $0.0375 $0.0485 52 767
Sep 18, 2019 $0.0390 $0.0500 $0.0390 $0.0500 16 739
Sep 17, 2019 $0.0600 $0.0600 $0.0390 $0.0484 15 733
Sep 16, 2019 $0.0400 $0.0600 $0.0400 $0.0570 85 694
Sep 13, 2019 $0.0392 $0.0550 $0.0390 $0.0550 29 895
Sep 12, 2019 $0.0470 $0.0500 $0.0390 $0.0500 74 504
Sep 11, 2019 $0.0390 $0.0558 $0.0390 $0.0538 7 413
Sep 10, 2019 $0.0487 $0.0613 $0.0487 $0.0600 71 992
Sep 09, 2019 $0.0597 $0.0597 $0.0390 $0.0581 14 127
Sep 06, 2019 $0.0463 $0.0573 $0.0439 $0.0573 58 011
Sep 05, 2019 $0.0463 $0.0463 $0.0439 $0.0440 8 053
Sep 04, 2019 $0.0484 $0.0484 $0.0439 $0.0450 7 197
Sep 03, 2019 $0.0378 $0.0484 $0.0378 $0.0470 8 975
Aug 30, 2019 $0.0390 $0.0484 $0.0390 $0.0470 32 578
Aug 29, 2019 $0.0400 $0.0484 $0.0390 $0.0484 10 043
Aug 28, 2019 $0.0365 $0.0454 $0.0365 $0.0454 47 325
Aug 27, 2019 $0.0365 $0.0440 $0.0365 $0.0390 19 693
Aug 26, 2019 $0.0415 $0.0440 $0.0400 $0.0436 1 600
Aug 23, 2019 $0.0366 $0.0439 $0.0366 $0.0439 16 714
Aug 22, 2019 $0.0403 $0.0431 $0.0403 $0.0431 11 182
Aug 21, 2019 $0.0440 $0.0440 $0.0361 $0.0431 10 969
Aug 20, 2019 $0.0351 $0.0441 $0.0351 $0.0441 4 500
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT